{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:14:07Z","timestamp":1761174847415,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T00:00:00Z","timestamp":1573603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.cmi.2019.10.033","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T19:22:50Z","timestamp":1573068170000},"page":"384.e5-384.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Bacillus Calmette\u2013Gu\u00e9rin strains with defined resistance mutations: a\u00a0new tool for tuberculosis laboratory quality control"],"prefix":"10.1016","volume":"26","author":[{"given":"S.N.","family":"Danchuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.B.","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Behr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2018","series-title":"Global tuberculosis report 2018. Licence: CC BY-NC-SA 3.0 IGO","author":"World Health Organization","key":"10.1016\/j.cmi.2019.10.033_bib1"},{"key":"10.1016\/j.cmi.2019.10.033_bib2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12879-018-3237-z","article-title":"Variability in distribution and use of tuberculosis diagnostic tests in Kenya: a cross-sectional survey","volume":"18","author":"Oliwa","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.033_bib3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/CMR.00059-10","article-title":"Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities","volume":"24","author":"Parsons","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2019.10.033_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1874285801812010009","article-title":"Programmatic impact of implementing GeneXpert MTB\/RIF assay for the detection of Mycobacterium tuberculosis in respiratory specimens from pulmonary tuberculosis suspected patients in resource limited laboratory settings of eastern Nepal","volume":"12","author":"Shrestha","year":"2018","journal-title":"Open Microbiol J"},{"key":"10.1016\/j.cmi.2019.10.033_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-4939-2450-9_10","article-title":"Mycobacterial recombineering","volume":"1285","author":"Murphy","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cmi.2019.10.033_bib6","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1128\/JCM.39.8.2987-2990.2001","article-title":"Mutations in the rpoB Gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India","volume":"39","author":"Mani","year":"2001","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.10.033_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cmi.2016.12.009","article-title":"Novel rapid PCR for the detection of Ile491Phe rpoB mutation of Mycobacterium tuberculosis, a rifampicin-resistance-conferring mutation undetected by commercial assays","volume":"23","author":"Andr\u00e9","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.10.033_bib8","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.5588\/ijtld.15.0864","article-title":"Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis","volume":"20","author":"Bollela","year":"2016","journal-title":"Int J TB Lung Dis"},{"key":"10.1016\/j.cmi.2019.10.033_bib9","doi-asserted-by":"crossref","first-page":"13609","DOI":"10.1073\/pnas.1507071112","article-title":"Population genomics of Mycobacterium tuberculosis in the inuit","volume":"112","author":"Lee","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"year":"2018","series-title":"Rapid communication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR\/RR-TB)","author":"World Health Organization (WHO)","key":"10.1016\/j.cmi.2019.10.033_bib10"},{"key":"10.1016\/j.cmi.2019.10.033_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120470","article-title":"Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review","volume":"10","author":"Avalos","year":"2015","journal-title":"PlOS One"},{"key":"10.1016\/j.cmi.2019.10.033_bib12","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/AAC.00037-14","article-title":"Cross-resistance between clofazimine and bedaquiline through upregulation of MmpL5 in Mycobacterium tuberculosis","volume":"58","author":"Hartkoorn","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.10.033_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41479-018-0049-2","article-title":"Rapid molecular assays for detection of tuberculosis","volume":"10","author":"Eddabra","year":"2018","journal-title":"Pneumonia"},{"key":"10.1016\/j.cmi.2019.10.033_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1128\/JCM.01771-16","article-title":"Detection of isoniazid-, fluoroquinolone-, amikacin-, and kanamycin-resistant tuberculosis in an automated, multiplexed 10-color assay suitable for point-of-care use","volume":"55","author":"Chakravorty","year":"2016","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.10.033_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1473-3099(18)30673-X","article-title":"Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study","volume":"19","author":"Z\u00fcrcher","year":"2019","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19305889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19305889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:24:44Z","timestamp":1761117884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19305889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1198743X19305889"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.10.033","relation":{},"ISSN":["1198-743X"],"issn-type":[{"type":"print","value":"1198-743X"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacillus Calmette\u2013Gu\u00e9rin strains with defined resistance mutations: a\u00a0new tool for tuberculosis laboratory quality control","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}